Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP

Background: The need for a highly efficacious vaccine against Plasmodium falciparum remains pressing. In this controlled human malaria infection (CHMI) study, we assessed the safety, efficacy and immunogenicity of a schedule combining two distinct vaccine types in a staggered immunization regimen: o...

书目详细资料
Main Authors:	Rampling, T, Ewer, K, Bowyer, G, Bliss, C, Edwards, N, Wright, D, Payne, R, Venkatraman, N, Snudden, C, Poulton, I, Roberts, R, Sinden, R, Gerry, S, Lawrie, A, Gilbert, S, Hill, A
格式:	Journal article
出版:	Oxford University Press 2016

相似书籍

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
由: Rampling, T, et al.
出版: (2018)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals.
由: Hodgson, S, et al.
出版: (2014)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
由: Rampling, T, et al.
出版: (2015)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
由: Rampling, T, et al.
出版: (2016)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
由: Bliss, C, et al.
出版: (2016)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
由: Tiono, AB, et al.
出版: (2018)

Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo
由: Ewer, K, et al.
出版: (2018)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
由: Ewer (nee Russell), K, et al.
出版: (2018)

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals
由: Hodgson, SH, et al.
出版: (2014)

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
由: Sheehy, S, et al.
出版: (2012)

A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
由: De Barra, E, et al.
出版: (2014)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
由: Sheehy, S, et al.
出版: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
由: Sheehy, S, et al.
出版: (2011)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
由: Alfred B Tiono, et al.
出版: (2018-01-01)

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.
由: Eoghan de Barra, et al.
出版: (2014-01-01)

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans
由: Sheehy, S, et al.
出版: (2012)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
由: Sheehy, S, et al.
出版: (2012)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
由: Mensah, V, et al.
出版: (2016)

RTS,S/AS01 vaccine (Mosquirix™): an overview
由: Matthew B. Laurens
出版: (2020-03-01)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
由: Dunachie, S, et al.
出版: (2006)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
由: Juliette Fortpied, et al.
出版: (2020-06-01)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
由: Victorine A Mensah, et al.
出版: (2016-01-01)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
由: Morter, R, et al.
出版: (2022)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
由: Ogwang, C, et al.
出版: (2013)

RTS,S/AS01 malaria vaccine in African children.
由: Hill, A
出版: (2012)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
由: Gosling, R, et al.
出版: (2015)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
由: Ewer (nee Russell), K, et al.
出版: (2016)

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine chad63-mva rh5 in a phase ia clinical trial
由: Payne, R, et al.
出版: (2017)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
由: Elias, S, et al.
出版: (2014)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
由: Aroosa Younis Nadeem, et al.
出版: (2022-04-01)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
由: Bliss, C, et al.
出版: (2018)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
由: O'Hara, G, et al.
出版: (2012)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
由: Kimani, D, et al.
出版: (2014)

Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I first-in-human trial
由: de Graaf, H, et al.
出版: (2021)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
由: Bejon, P, et al.
出版: (2009)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
由: Roly Gosling, et al.
出版: (2016-04-01)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
由: Rowland, R, et al.
出版: (2012)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
由: Richard Morter, et al.
出版: (2022-12-01)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
由: Caroline Ogwang, et al.
出版: (2013-01-01)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
由: Hans de Graaf, et al.
出版: (2021-07-01)